These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 7391173)

  • 41. Pegloticase for treating refractory chronic gout.
    George RL; Sundy JS
    Drugs Today (Barc); 2012 Jul; 48(7):441-9. PubMed ID: 22844655
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of the binding between uric acid and plasma proteins (author's transl)].
    Sforza GR; Marcolongo R; Della Fazia L; Masciangelo F; Morozzi G; Lo Cosmo C
    Quad Sclavo Diagn; 1980 Dec; 15(4):1075-89. PubMed ID: 7454962
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adaptation of the SMAC for the determination of uric acid with an uricase/perioxidase procedure (author's transl)].
    Scholer A; Müller E; Toth F; Vonderschmitt DJ
    J Clin Chem Clin Biochem; 1978 Apr; 16(4):255-7. PubMed ID: 641455
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intermittent elevation of serum urate and 24-hour urinary uric acid excretion.
    Yu KH; Luo SF; Tsai WP; Huang YY
    Rheumatology (Oxford); 2004 Dec; 43(12):1541-5. PubMed ID: 15328425
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Efficacy and safety of a urate lowering regimen in primary gout.
    Bailén R; González Senac NM; López MM; Llena ML; Migoya M; Rodríguez MT; de Miguel E; Torres RJ; Puig JG
    Nucleosides Nucleotides Nucleic Acids; 2014; 33(4-6):174-80. PubMed ID: 24940666
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Decreased serum concentrations of 1,25(OH)2-vitamin D3 in patients with gout.
    Takahashi S; Yamamoto T; Moriwaki Y; Tsutsumi Z; Yamakita J; Higashino K
    Adv Exp Med Biol; 1998; 431():57-60. PubMed ID: 9598031
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Gout with normal serum urate concentration.
    Snaith ML; Coomes EN
    Br Med J; 1977 Mar; 1(6062):685-6. PubMed ID: 843870
    [No Abstract]   [Full Text] [Related]  

  • 48. Pegloticase (krystexxa) for treatment of refractory gout.
    Med Lett Drugs Ther; 2011 Feb; 53(1357):9-10. PubMed ID: 21304442
    [No Abstract]   [Full Text] [Related]  

  • 49. Evaluation and treatment of gout as a chronic disease.
    Perez-Ruiz F; Herrero-Beites AM
    Adv Ther; 2012 Nov; 29(11):935-46. PubMed ID: 23104464
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The effect of fructose on uric acid metabolism].
    Holländer E
    Acta Med Acad Sci Hung; 1974; 31(3-4):147-55. PubMed ID: 4469712
    [No Abstract]   [Full Text] [Related]  

  • 51. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: a phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study.
    Hosoya T; Ogawa Y; Hashimoto H; Ohashi T; Sakamoto R
    J Clin Pharm Ther; 2016 Jun; 41(3):290-7. PubMed ID: 27109450
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urate oxidase for the prevention and treatment of tumour lysis syndrome in children with cancer.
    Cheuk DK; Chiang AK; Chan GC; Ha SY
    Cochrane Database Syst Rev; 2014 Aug; (8):CD006945. PubMed ID: 25121561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Clinical trial of urate oxidase].
    Asch L
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):129-36. PubMed ID: 4563393
    [No Abstract]   [Full Text] [Related]  

  • 54. Tophaceous Gout in an Anorectic Patient Visualized by Dual Energy Computed Tomography (DECT).
    Christensen HD; Sheta HM; Morillon MB; Hansen IM
    Am J Case Rep; 2016 Jul; 17():494-8. PubMed ID: 27418121
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [New trend in gout treatment. Clinical and biological study of urate oxidase].
    Mizon JP; Plaquet R; Gentit F; Quiret JC
    Lille Med; 1971 Nov; 16(9):1332-45. PubMed ID: 4945000
    [No Abstract]   [Full Text] [Related]  

  • 56. [The uric acid-lowering effect of diflunisal].
    Fasching U
    Wien Klin Wochenschr; 1987 Nov; 99(22):791-3. PubMed ID: 3433782
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An association of smoking with serum urate and gout: A health paradox.
    Fanning N; Merriman TR; Dalbeth N; Stamp LK
    Semin Arthritis Rheum; 2018 Jun; 47(6):825-842. PubMed ID: 29398126
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Unusual clinical syndrome: rheumatoid arthritis and gouty arthritis].
    Misz I; Vizi F
    Orv Hetil; 1987 Dec; 128(51):2695-6, 2699-700. PubMed ID: 3324002
    [No Abstract]   [Full Text] [Related]  

  • 59. [Serum uric acid reference values: clinical nonsense as a measure of quality].
    Löffler W
    MMW Fortschr Med; 2015 Apr; 157(6):57-8. PubMed ID: 26015210
    [No Abstract]   [Full Text] [Related]  

  • 60. Exploratory study of radiographic change in patients with tophaceous gout treated with intensive urate-lowering therapy.
    Dalbeth N; Doyle AJ; McQueen FM; Sundy J; Baraf HS
    Arthritis Care Res (Hoboken); 2014 Jan; 66(1):82-5. PubMed ID: 23836458
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.